2019
$80M
from 13 investors over 13 rounds
AN2 Therapeutics raised $70M on August 15, 2023
Investors: TCG X, Avidity Partners, Adage Capital Management, RA Capital Management, L.P., Surveyor Capital and Marshall Wace
AN2 Therapeutics raised $80M on January 7, 2022
Investors: Avidity Partners, Monashee Investment Management LLC, RA Capital Management, L.P. and Surveyor Capital
AN2 Therapeutics raised $12M on November 21, 2019
Investors: Mountain Group Partners, Adjuvant Capital and Brii Biosciences